| Name | Title | Contact Details |
|---|
Your partner in Care is a Wakefield, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sarasota Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sarasota, FL. To find more information about Sarasota Memorial Hospital, please visit www.smh.com
Therapy Pros, LLC is a Bloomfield Hills, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Riverview Health is comprised of a full-service, 156-bed hospital in Noblesville, a 16-bed hospital in Westfield, as well as freestanding combined ER and urgent care facilities. Also included are more than 25 primary, immediate and specialty-care facilities in Hamilton County. Riverview Health provides comprehensive inpatient and outpatient services in more than 35 healthcare specialties and has been frequently recognized for its clinical and service excellence, including being named America`s 100 Best Hospitals for Orthopedic Surgery by Healthgrades and earning the Healthgrades Outstanding Patient Experience award. For more information on Riverview Health, visit riverview.org.Together, we provide comprehensive inpatient and outpatient services in more than 35 healthcare specialties—and have been frequently recognized for our clinical and service excellence. A wide range of services is provided at our main campus—located at 395 Westfield Rd. in Noblesville—including comprehensive care in heart & vascular, orthopedics, advanced emergency services and a vast array of women`s health services. As one of the largest employers in Hamilton County, Riverview Health employs more than 1,400 employees, thereby having a significant impact on the local economy. Riverview Health is owned by the county and does not receive tax dollars for operating expenses.
BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein evolution technologies is our Conditionally Active Biologics (CAB)platform. Monoclonal antibodies or enzymes can be engineered for selective conditional activation, i.e. the protein`s functions are designed to modulate with changes in microphysical conditions (e.g., pH level, oxidation, temperature, pressure concentration, presence of certain ions, hydrophobicity and competing protein binding). Tumors and other kinds of diseased tissue give rise to unique localized conditions distinct from normal tissue. CAB designed monoclonal antibodies can be programmed to deliver an ADC payload and/or recruit the immune response to specific sites and conditions in the body.